Dimitri Gagliardi

Dimitri Gagliardi

Auto-generated profile, based on publicly available information

Dimitri Gagliardi

Manchester Institute of Innovation Research, Alliance Manchester Business School The University of Manchester Manchester UK

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015
Verified
Book Chapter
Open access
PDF file
DGDimitri Gagliardi
Dimitri Gagliardi
DCDeborah Cox
Deborah Cox
YLYanchao Li
Yanchao Li

4 July 2019 in R&D Management
Verified
Journal Article
Open access
PDF file
XLXiuqin Li
Xiuqin Li
DGDimitri Gagliardi
Dimitri Gagliardi
IMIan Douglas Miles
Ian Douglas Miles
Research and development service firms (RDSFs) are a particular type of technology‐based knowledge‐intensive business services (KIBS). RDSFs provide clients with R&D services on a contract basis, and operate as knowledge intermediaries linking research and market. They are innovative in their own right, as well as supporting innovation efforts by their clients; they rely on their own innovation efforts to be competitive and to develop new value propositions for their clients. The present paper explores the innovation process in RDSFs, drawing on semi‐structured interviews with founders and senior managers of 32 companies in the United Kingdom. Our findings suggest that RDSFs vary considerably in terms of their primary innovation drivers (i.e. whether they are mainly driven by market demands or by technological opportunities) and the outcomes they pursue (i.e. whether their outputs are mainly services to clients or a mixture of services and products and/or intellectual property). Four major orientations of RDSFs were identified: (i) technology‐based innovation exploiters; (ii) science‐focused innovation explorers; (iii) client‐driven innovation integrators; and (iv) open innovation translators. This variety among firms normally belonging to the same, small subsector of KIBS, suggests the need for caution in generalising about behaviour in terms of such statistical groupings.

1 September 2018 in Technological Forecasting and Social Change
Verified
Journal Article
Closed access
DGDimitri Gagliardi
Dimitri Gagliardi
RRRonnie Ramlogan
Ronnie Ramlogan
PNPierluigi Navarra
Pierluigi Navarra
DCDello Russo Cinzia
Dello Russo Cinzia

1 January 2019
Verified
Conference Paper
Open access
PDF file
DGDimitri Gagliardi
Dimitri Gagliardi
GMGianluca Misuraca
Gianluca Misuraca
FNFrancesco Niglia
Francesco Niglia
GPGiulio Pasi
Giulio Pasi
The paper investigates the role of Information and Communication Technologies (ICTs) in enabling social innovation and civic engagement. The purpose is to advance a typology for better understanding whether such a phenomenon might contribute to a paradigmatic shift in the relationship between the governments or the administrations and citizens. This framework is based on the review of recent literature on social innovation and ICTs, studying the relationships between government and citizens emerging from 41 cases. The analysis highlights how ICTs underpin innovation in civic engagement initiatives in two main ways: 1) by modernising existing processes and 2) by integrating new services.

2 May 2023 in Innovation
Verified
Journal Article
Closed access
YXYingyong Xu
Yingyong Xu
DGDimitri Gagliardi
Dimitri Gagliardi
In the last two decades, efforts in cancer treatment have been progressing rapidly in terms of scientific discoveries and development of new therapeutic solutions. Medical innovation contributes to significant survival gains for cancer patients. Yet, cancer remains one of the leading causes of death and one of the most pressing public health challenges worldwide. We propose an interpretative lens that refers to the idea of ‘anomaly’ as a driver of new technological paradigms to interpret new and emerging developments in medical innovation and in cancer treatment in particular. We use the lens of gateways to innovation and pathways of innovation to investigate how the organisation of (i) knowledge generation, (ii) technological applications and (iii) new clinical approaches emerge and are refined. We adopt a historical/longitudinal method following research and clinical outcomes in three ‘illustrative’ cases of cancer. Cancer is a heterogeneous, complex disease and is constantly evolving; thus, it remains a ‘persistent anomaly’. Research and clinical innovation activities have recently made great strides in understanding specific aspects of the disease and generated truly innovative therapeutic options in some areas, whilst in other areas, progress is lagging. At the same time, research and innovation activities have been employed to refine existing techniques, drugs and diagnostics providing improved treatment solutions across the related disease areas. Throughout its recent history, cancer research and innovation promoted several new paradigms tackling different aspects of the disease engendering new trajectories that have been implemented in conjunction with established and improved practices.